The living cell supply chain: a product-specific, rational approach to management of cellular starting material donors & donations
Cell & Gene Therapy Insights 2022; 8(10), 1375–1379
DOI: 10.18609/cgti.2022.201
Published: 18 November 2022
Viewpoint
William E Janssen, WEJ Cell and Gene Therapy Consulting Services, & Scott R Burger, Advanced Cell and Gene Therapy, LLC